Lapatinib Completed Phase 2 Trials for recurrent, IV-B Cervical cancer / Neoplasms, Uterine Cervix Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00430781Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer